Shan et al reported NAP1L1 as a regulator of cardiac fibrosis, particularly in ischemic cardiomyopathy, through inhibition of YAP1 ubiquitination and degradation in cardiac fibroblasts43. The gene discussed is NAP1L1; the disease is ischemic cardiomyopathy.